COVID-19 : : Diagnosis and Management - Part I.

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:Sharjah : : Bentham Science Publishers,, 2021.
Ã2021.
Year of Publication:2021
Edition:1st ed.
Language:English
Online Access:
Physical Description:1 online resource (223 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Cover
  • Title
  • Copyright
  • End User License Agreement
  • Contents
  • Foreword
  • Preface
  • List of Contributors
  • Chapter 1
  • Sunishtha1, Govind Singh1 and Sanju Nanda1,*
  • INTRODUCTION
  • THE ATHENIAN PLAGUE
  • PLAGUE OF JUSTINIAN
  • THE BLACK DEATH
  • SPANISH FLU
  • AIDS
  • SMALLPOX
  • SARS
  • SWINE FLU OR H1N1 PANDEMIC
  • EBOLA
  • COVID-19
  • ORIGIN OF CORONAVIRUS
  • TYPES OF CORONAVIRUSES
  • DISEASE ASSOCIATED WITH CORONAVIRUSES
  • MURINE HEPATITIS VIRUS (MHV)
  • Central Nervous System
  • Hepatitis
  • Pneumonitis
  • BOVINE CORONAVIRUS
  • HUMAN CORONAVIRUS
  • ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Chapter 2
  • Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1
  • INTRODUCTION
  • GENOMIC STRUCTURE OF CORONAVIRUS
  • STRUCTURAL PROTEINS
  • Spike Protein
  • Small Membrane Protein
  • Membrane Protein
  • Hemagglutinin-Esterase
  • Nucleocapsid and Internal Proteins
  • Replicase Protein
  • VIRAL CYCLE
  • OUTBREAKS OF CORONAVIRUS
  • Porcine Coronavirus
  • Avian Coronavirus
  • Feline Coronavirus
  • Bovine Coronavirus
  • Murine Coronavirus
  • Human Coronavirus
  • SARS-CoV
  • MERS-CoV
  • COVID-19
  • Introduction
  • Chronology of COVID-19
  • Symptoms
  • Transmission
  • Treatment
  • LIST OF ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Chapter 3
  • Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,*
  • INTRODUCTION
  • GEOGRAPHICAL DISTRIBUTION
  • GLOBAL EPIDEMIOLOGY OF COVID-19
  • Effect of Age, Sex and other Factors on Covid-19-Related Deaths
  • COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020)
  • COVID-19 IN INDIA
  • REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA
  • NATIONAL RESPONSES ON COVID-19 WORLDWIDE.
  • Asia
  • China
  • South Korea
  • Middle Eastern
  • Iran
  • Europe
  • Spain
  • France
  • North America
  • United States
  • South America
  • Africa
  • Oceania
  • EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD
  • THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19
  • OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY
  • Herd Immunity-COVID-19
  • CONCLUSION
  • LIST OF ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Chapter 4
  • Anirban Ghosh1 and Shamsher Singh1,*
  • INTRODUCTION
  • TRANSMISSION OF COV
  • Virus Life Cycle
  • Role of Structural Proteins in The Pathogenesis
  • A. Spike Protein
  • B. Hemagglutinin-Esterase (HE) Protein
  • C. Membrane (M) Protein
  • D. Small Envelop (E) Protein
  • E. Nucleocapsid (N) Protein and Internal (I) Protein
  • F. Replicase Proteins
  • G. CoV Associated Protein
  • Pathophysiology from a Cell Biology Perspective
  • Phase I. Asymptomatic Stage (First 1-2 Days of Infection)
  • Phase II. Upper Airway and Conducting Airway Response (Next Few Days)
  • Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs
  • CONCLUSION
  • LIST OF ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Chapter 5
  • Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,*
  • INTRODUCTION
  • CLINICAL PRESENTATIONS OF COVID-19 INFECTION
  • INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19
  • Neonates or Newborns (Upto 1 Month)
  • Infants (1 Month-2 Years), Children (2-10 Years)
  • Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients
  • Elderly (&gt
  • 60 Years) and Older (&gt
  • 80 Years) Patients
  • ACE2
  • Gender
  • Blood Group
  • Previous Immunization
  • COMORBIDITY
  • CONCLUSION.
  • LIST OF ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Chapter 6
  • Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,*
  • COVID-19: A PANDEMIC DISEASE
  • COVID-19: EARLY DETECTION BASED ON SYMPTOMS
  • Clinical Analysis
  • Hematological Analysis
  • Chest CT
  • COVID-19: MOLECULAR DETECTION OF VIRUS
  • RT-PCR Based Assays
  • Loop Mediated Isothermal Amplification (LAMP)
  • CRISPR-Isothermal Amplification Based Assays
  • Microarrays
  • Metagenomic Sequencing Based Methods
  • Gold Nanoparticles-Based Colorimetric Assay
  • COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION
  • BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM
  • Antibody Biomarkers
  • Antigen Biomarkers
  • Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers
  • SEROLOGICAL AND IMMUNOLOGICAL ASSAYS
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Lateral Flow Immunoassay
  • Neutralization Assays
  • Luminescence-based Immunoassays
  • Biosensor Tests
  • Rapid Antigen Tests
  • CONCLUDING REMARKS
  • LIST OF ABBREVIATIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Subject Index.